IOVANCE BIOTHERAPEUTICS UK SP LTD

Company number 08588212

Date	Type	Description	View / Download
25 Aug 2021	AP01	Appointment of Mr Richard John Paling as a director on 24 August 2021	(2 pages)
25 Aug 2021	TM01	Termination of appointment of Nicholas Patrick Keher as a director on 24 August 2021	(1 page)
21 Jun 2021	CS01	Confirmation statement made on 31 May 2021 with no updates	(3 pages)
21 Jun 2021	RP04CS01	Second filing of Confirmation Statement dated 31 May 2020	(3 pages)
24 Mar 2021	AA	Audit exemption subsidiary accounts made up to 30 June 2020	(17 pages)
10 Dec 2020	PARENT_ACC	Consolidated accounts of parent company for subsidiary company period ending 30/06/20	(131 pages)
10 Dec 2020	AGREEMENT2	Notice of agreement to exemption from audit of accounts for period ending 30/06/20	(1 page)
10 Dec 2020	GUARANTEE2	Audit exemption statement of guarantee by parent company for period ending 30/06/20	(3 pages)
09 Jul 2020	AA	Full accounts made up to 30 June 2019	(19 pages)
01 Jun 2020	CS01	Confirmation statement made on 31 May 2020 with updates ANNOTATION Clarification a second filed CS01 statement of capital & shareholder information was registered on 21/06/21	(5 pages)
03 Mar 2020	SH01	Statement of capital following an allotment of shares on 4 November 2019 GBP 1 USD 18,000,000	(3 pages)
24 Jun 2019	RESOLUTIONS	Resolutions RES12 ‐ Resolution of varying share rights or name RES01 ‐ Resolution of adoption of Articles of Association	(12 pages)
17 Jun 2019	PSC02	Notification of Clinigen Holdings Limited as a person with significant control on 27 March 2019	(2 pages)
17 Jun 2019	PSC07	Cessation of Clinigen Pharma Limited as a person with significant control on 27 March 2019	(1 page)
17 Jun 2019	CS01	Confirmation statement made on 31 May 2019 with updates	(5 pages)
17 Jun 2019	SH01	Statement of capital following an allotment of shares on 22 May 2019 GBP 1 USD 12,000,000	(3 pages)
21 Mar 2019	AP01	Appointment of Nicholas Patrick Keher as a director on 19 March 2019	(2 pages)
21 Mar 2019	TM01	Termination of appointment of Martin James Abell as a director on 19 March 2019	(1 page)
14 Mar 2019	AAMD	Amended accounts for a dormant company made up to 30 June 2018	(3 pages)
16 Jul 2018	CS01	Confirmation statement made on 31 May 2018 with updates	(4 pages)
04 Jul 2018	AA	Unaudited abridged accounts made up to 30 June 2018	(6 pages) Download iXBRL
23 Oct 2017	AA	Accounts for a dormant company made up to 30 June 2017	(4 pages)
18 Jul 2017	PSC02	Notification of Clinigen Pharma Limited as a person with significant control on 28 June 2017	(1 page)
18 Jul 2017	AP03	Appointment of Amanda Miller as a secretary on 13 July 2017	(2 pages)
17 Jul 2017	TM02	Termination of appointment of Martin James Abell as a secretary on 13 July 2017	(1 page)